Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B by Charlotte Schubert on July 22, 2021July 23, 2021 at 9:45 am Shares of Absci surged more than 30% on Thursday as the Vancouver, Wash.-based biotech company made its debut as a public company. Absci priced its stock at $16 per share… Read More